|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 20, 2017 ) Publisher's clinical trial report "Cervical Cancer Global Clinical Trials Review H1 2017" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region country (G7 & E7) phase trial status end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials) . Publisher Clinical Trial Reports are generated using Publisher's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries conferences journals news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
For more information about this report at http://www.reportsweb.com/cervical-cancer-global-clinical-trials-review-h1-2017
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region Country (G7 & E7) Trial Status Trial Phase Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title Phase and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global regional and country level
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001881632/sample
Table of Content
List of Tables 4
List of Figures 5
Report Guidance 6
Publisher Clinical Trials Report Coverage 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries Proportion of Cervical Cancer to Oncology Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries Proportion of Cervical Cancer to Oncology Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Cervical Cancer Therapeutics Clinical Trials 29
Prominent Drugs 30
Latest Clinical Trials News on Cervical Cancer 31
Jun 02 2017 Opdivo (nivolumab) Data in Patients with Advanced Cervical Vaginal and Vulvar Cancers from Phase 1/2 CheckMate -358 Presented at ASCO 31
May 18 2017 Advaxis to Host Investor & Analyst Day on June 12 31
Apr 18 2017 Lion Biotechnologies Highlights Publication of New Translational Data in Science for TIL Therapy for Treatment of Cervical Cancer 32
Mar 27 2017 Advaxis Provides Phase 1 Data of Higher Dose Axalimogene Filolisbac 32
Mar 23 2017 Vaccibody Announces Vaccination Of First Patient In Its Phase IIA Study With VB10.16 Immunotherapy For Patients With HPV16 Induced High Grade Lesions Of The Cervix 32
Mar 15 2017 Advaxis Presents Oral Late-breaking Data on Phase 2 GOG-0265 Study of Axalimogene Filolisbac at SGO's Annual Meeting on Women's Cancer 33
Clinical Trial Profile Snapshots 35
Appendix 502
Abbreviations 502
Definitions 502
Research Methodology 503
Secondary Research 503
About Publisher 504
Contact Us 504
Disclaimer 504
Source 504
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001881632/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
